Dual roles of drug or its metabolite−protein conjugate: Cutting‐edge strategy of drug discovery using shotgun proteomics.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 4, p. 1704, doi. 10.1002/med.21889
- By:
- Publication type:
- Article
Works matching IS 01986325 AND DT 2022 AND VI 42 AND IP 4
Results: 12
1
2
Purinergic receptors modulators: An emerging pharmacological tool for disease management.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 4, p. 1661, doi. 10.1002/med.21888
- By:
- Publication type:
- Article
3
Targeting key proteins involved in transcriptional regulation for cancer therapy: Current strategies and future prospective.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 4, p. 1607, doi. 10.1002/med.21886
- By:
- Publication type:
- Article
4
Recent progress in the imaging of c‐Met aberrant cancers with positron emission tomography.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 4, p. 1588, doi. 10.1002/med.21885
- By:
- Publication type:
- Article
5
Incomplete autophagy: Trouble is a friend.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 4, p. 1545, doi. 10.1002/med.21884
- By:
- Publication type:
- Article
6
Metabolomics as a tool for the early diagnosis and prognosis of diabetic kidney disease.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 4, p. 1518, doi. 10.1002/med.21883
- By:
- Publication type:
- Article
7
Issue Information.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 4, p. 1373, doi. 10.1002/med.21828
- Publication type:
- Article
8
Epigenetic modification in alcohol‐related liver diseases.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 4, p. 1463, doi. 10.1002/med.21881
- By:
- Publication type:
- Article
9
Skin cancer, including related pathways and therapy and the role of luteolin derivatives as potential therapeutics.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 4, p. 1423, doi. 10.1002/med.21880
- By:
- Publication type:
- Article
10
Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug‐resistant infections.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 4, p. 1377, doi. 10.1002/med.21879
- By:
- Publication type:
- Article
11
Front Cover Image, Volume 42, Issue 4.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 4, p. i, doi. 10.1002/med.21829
- By:
- Publication type:
- Article
12
Genetically modified cancer vaccines: Current status and future prospects.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 4, p. 1492, doi. 10.1002/med.21882
- By:
- Publication type:
- Article